Simplified V2.3c | Commander BND Monthly | NVDA & LLY Edition
Today’s Change (Mar 5, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
Monthly, concentrated toggle between NVIDIA (tech/semis) and Eli Lilly (pharma). 80% follows stock/bond trend checks; 20% picks the one with stronger recent momentum (RSI). Uses SPY, BND, and TLT as market signals.
Rebalances monthly. 80% core: If the S&P 500 (SPY) just fell hard, hold Eli Lilly (LLY, big pharma). Otherwise, if broad bonds (BND) were up over ~3 months, hold NVIDIA (NVDA, chipmaker). If bonds were weak, check long Treasuries (TLT): if short‑term improving vs prior 4 months, hold LLY; else NVDA. 20% satellite: holds whichever of NVDA/LLY has the stronger 90‑day strength score (RSI = more up days than down).
Out-of-sample edge: 31.74% annualized return vs SPY 18.25%; Calmar 1.08. Higher drawdowns (29.36% vs 18.76%), but a disciplined, momentum-driven NVDA/LLY strategy guided by macro signals offers compelling upside per unit risk.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| 0.32 | 1.21 | 0.37 | 0.61 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 540.43% | 10.49% | -0.15% | 0.4% | 0.6 | |
| 139,693.27% | 47.54% | 1.93% | -0.35% | 1.18 |
Initial Investment
$10,000.00
Final Value
$13,979,326.83Regulatory Fees
$2,097.24
Total Slippage
$14,158.12
Invest in this strategy
OOS Start Date
Jun 23, 2024
Trading Setting
Monthly
Type
Stocks
Category
Monthly rotation, momentum timing, concentrated, tech vs pharma, bond-signal overlay, aggressive